Rebecca Karp Leaf
- Hematology top 10%
- Platelet Disorders and Treatments 6
- Blood groups and transfusion 6
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
-
- Cancer Immunotherapy and Biomarkers 5
-
- Eosinophilic Disorders and Syndromes 6
-
- Porphyrin Metabolism and Disorders 12
- Heme Oxygenase-1 and Carbon Monoxide 10
-
- Methemoglobinemia and Tumor Lysis Syndrome 7
- Co-authors
- Amy K. DickeyDavid E. LeafHanny Al‐SamkariKerry L. ReynoldsKatayoon GoodarziDavid AviganJean M. ConnorsSara Schoenfeld
- Cited by
- HematologyGeneticsOncology
- Journals
- New England Journal of Medicine (3 papers)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Rebecca Karp Leaf
46 papers receiving 384 citations
Peers
Comparison fields: 5 of 70
- Hematology 131
- Genetics 82
- Oncology 111
- Rheumatology 48
- Immunology 59
Countries citing papers authored by Rebecca Karp Leaf
This map shows the geographic impact of Rebecca Karp Leaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Karp Leaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Karp Leaf more than expected).
Fields of papers citing papers by Rebecca Karp Leaf
This network shows the impact of papers produced by Rebecca Karp Leaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Karp Leaf. The network helps show where Rebecca Karp Leaf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rebecca Karp Leaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 2 | |
| 14 | 2019 | 24 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 49 | |
| 17 | 2019 | 34 | |
| 18 | 2017 | 10 | |
| 19 | 2017 | 23 | |
| 20 | 2016 | 1 |
About Rebecca Karp Leaf
Rebecca Karp Leaf is a scholar working on Hematology, Genetics and Rheumatology, having authored 53 papers that have together received 395 indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (12 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Methemoglobinemia and Tumor Lysis Syndrome (7 papers), Platelet Disorders and Treatments (6 papers), Eosinophilic Disorders and Syndromes (6 papers), Blood groups and transfusion (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Hematology (131 citations), Genetics (82 citations) and Oncology (111 citations). Rebecca Karp Leaf has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Amy K. Dickey, David E. Leaf, Hanny Al‐Samkari, Kerry L. Reynolds, Katayoon Goodarzi, David Avigan, Jean M. Connors, Sara Schoenfeld, Michael Dougan and Amy Sullivan. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.